News Industry News Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device July 02, 2012
News Industry News Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy May 11, 2012
News Industry News Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent March 20, 2012
News Industry News Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America November 15, 2011
News Industry News Boston Scientific Announces Schedule of Events at TCT Scientific Symposium November 01, 2011
News Industry News Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device May 18, 2011
News Industry News Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech March 02, 2011